POTENTIAL RELEVANCE OF CHANGES IN HEMATOCRIT TO CHANGES IN LIPID PARAMETERS WITH EMPAGLIFLOZIN IN PATIENTS WITH TYPE 2 DIABETES MELLITUS (T2DM)
AACE ePoster Library. Lund S. 05/27/16; 131474; 294
Søren Lund
REGULAR CONTENT
Login now to access Regular content available to all registered users.
Rate & Comment (0)
{{ help_message }}
{{filter}}